Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 9, 2005
- Accepted May 5, 2005
- Published online July 1, 2005.
Copyright & Usage
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- CHIKARA KUNISAKI1,
- TOSHIO IMADA1,
- ROPPEI YAMADA1,
- SHINSUKE HATORI1,
- HIDETAKA ONO2,
- YUICHI OTSUKA2,
- GORO MATSUDA2,
- MASATO NOMURA2,
- HIROTOSHI AKIYAMA2,
- AKIRA KUBO3 and
- HIROSHI SHIMADA2
- 1Department of Surgery, Gastroenterological Center, Yokohama City University, Graduate School of Medicine, Yohohama
- 2Department of Gastroenterological Surgery, Yokohama City University, Graduate School of Medicine, Yohohama
- 3Department of Surgery, Yokosuka Municipal Hospital, Yokosuka, Japan
- Correspondence to: Chikara Kunisaki, MD, Department of Surgery, Gastroenterological Center, 4-57, Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan. Tel: +81-45-261-5656, Fax: +81-45261-9492, e-mail: s0714{at}med.yokohama-cu.ac.jp
Statistics from Altmetric.com
Cited By...
Jump to section
Related Articles
Cited By...
- Modified Docetaxel-cisplatin in Combination with Capecitabine as First-line Treatment in Metastatic Gastric Cancer. A Phase II Study
- The Role of Chemotherapy in Metastatic Gastric Cancer
- Phase II Study of Weekly Paclitaxel as a Second-line Treatment for S-1-refractory Advanced Gastric Cancer
- Is There an Optimal Chemotherapy Regimen for the Treatment of Advanced Gastric Cancer That Will Provide a Platform for the Introduction of New Biological Agents?